-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The acute sequelae of coronavirus disease 2019 ( COVID-19 ) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may involve the lungs and several extrapulmonary organs, including the cardiovascular system .
Infection with COVID-19 blood vessels
A comprehensive assessment of the acute cardiovascular sequelae of COVID-19 has not yet been performed, and various therapeutic approaches (ambulatory, hospitalized, and intensive care unit admission) for acute infection are lacking
In a study published today in the top medical journal Nature Medicine, researchers used the U.
cardiovascular events
Researchers found that 30 days after SARS-CoV-2 infection, COVID-19 patients were at increased risk of developing cardiovascular disease, including cerebrovascular disease, arrhythmias , ischemic and nonischemic heart disease, pericarditis, myocarditis, Heart failure and thromboembolic disease
arrhythmia thrombosis
Thus, this study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial
This study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial
Original source:
Yan Xie, et al.